Monitor for continued open-market selling above $1M; current activity reflects routine option monetization, not distress. No signal of fundamental change.
Price Chart
Executive Summary
United Therapeutics insiders executed a cluster of derivative exercises and open-market sales over the past week, led by CEO Martine Rothblatt and CFO James Edgemon. The activity includes $5.7 million in exercised derivative value and $467,238 in open-market share sales, representing routine equity management rather than a material shift in sentiment.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt exercised derivatives for 38,000 shares at $146.03 (total value $5.55M) and sold 440 shares for $229,936 in open market.
- CFO James Edgemon exercised derivatives for 20,000 shares at $135.42 (value $2.71M) and sold 200 shares for $103,657.
- Director Tommy Thompson exercised derivatives for 4,000 shares at $101.80 (value $407,200) and sold 275 shares for $147,845.
- Director Judy Olian sold 200 shares for $106,000.
- All derivative exercises were paired with non-cash transactions (code M at $0), consistent with standard option exercise mechanics.
- Total open-market sales: 1,115 shares valued at $467,238 over 7 days; average daily volume remains stable.
Financial Impact
$467,238 in open-market sales and $5.7M in derivative exercises over 7 days
Risk Factors
- Perception risk if media misinterprets derivative exercises as large-scale insider selling
- Potential for short-term price pressure if selling pace accelerates
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (19 trades, 7d window) | cluster-UTHR-1774557312992 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $552.73 (+10.47%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $552.73 (+11.19%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $552.73 (+9.70%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $552.73 (+9.06%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $552.73 (+13.36%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $552.73 (+13.23%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $552.73 (+7.23%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $552.73 (+4.70%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $552.73 (+6.98%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $552.73 (+6.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access